Crohn's Disease News and Research

Latest Crohn's Disease News and Research

Scientists elucidate mechanism behind early loss of vaccination protection in people with autoimmune disease

People who are treated with TNF-α inhibitors for their autoimmune disease such as Crohn's disease or rheumatoid arthritis lose their vaccination protection significantly earlier than average.

7 Sep 2023

Statins may protect IBD patients from colorectal cancer, study finds

Cholesterol-lowering statins might protect patients with ulcerative colitis from developing and dying from colorectal cancer.

1 Sep 2023

Artificial intelligence may influence whether you can get pain medication

Elizabeth Amirault had never heard of a Narx Score. But she said she learned last year the tool had been used to track her medication use.

30 Aug 2023

Age-related changes in the blood system can exacerbate colon cancer

Researchers at the University of Florida College of Medicine have discovered how common age-related changes in the blood system can make certain colon cancers grow faster.

24 Aug 2023

Doctors and patients try to shame insurers online to reverse prior authorization denials

Sally Nix was furious when her health insurance company refused to pay for the infusions she needs to ease her chronic pain and fatigue.

23 Aug 2023

Beneficial gut bacteria use mucus lining to stay in place, study finds

When it comes to gut health, it doesn't just matter who's invited to the party, but how they behave.

18 Aug 2023

Experimental drug can reduce symptoms of inflammatory bowel disease in pre-clinical models

A new study of mice and lab-grown human colon "organoids" indicates that an experimental drug developed by Johns Hopkins Medicine researchers can substantially reduce symptoms of inflammatory bowel disease (IBD) in pre-clinical models.

10 Aug 2023

Is there an association between migraines and the onset of inflammatory bowel disease?

The link between migraines and the new onset of inflammatory bowel disease (IBD).

4 Aug 2023

Maintaining the health of the gut microbiome by a new peptide

Peptide YY (PYY), a hormone produced by gut endocrine cells that was already known to control appetite, also plays an important role in maintaining the balance of fungi in the digestive system of mammals, according to new research from the University of Chicago.

4 Aug 2023

Stem cells offer new hope for Crohn's disease treatment

Research from Ann & Robert H. Lurie Children's Hospital of Chicago found that direct injection of neonatal mesenchymal stem cells, derived from heart tissue discarded during surgery, reduces intestinal inflammation and promotes wound healing in a mouse model of Crohn's disease-like ileitis, an illness marked by chronic intestinal inflammation and progressive tissue damage.

28 Jul 2023

Are antidrug antibodies reducing the effectiveness of rheumatoid arthritis treatment?

Researchers examined the association between antidrug antibodies and the response to treatments for rheumatoid arthritis.

17 Jul 2023

Candidate genes for inflammatory bowel disease identified

A study of the genetic variation that makes mice more susceptible to bowel inflammation after a high-fat diet has identified candidate genes which may drive inflammatory bowel disease (IBD) in humans. The findings are published as a Reviewed Preprint in eLife.

5 Jul 2023

New drug effective as a treatment against ulcerative colitis, clinical trial shows

A new drug, investigated by Amsterdam UMC together with colleagues around the world, is effective as a treatment against ulcerative colitis.

28 Jun 2023

Measurable upticks in gut bacteria blooms tied to lupus flare-ups

Recurrent bouts of systemic lupus erythematosus, marked by the body's immune system attack of its own tissues, closely tracked with measurable upticks in growth in the gut of a certain species of bacteria.

27 Jun 2023

Research sheds light on how steroids affect cancer Immunotherapy

Immunotherapy is among the newest and most potent weapons against cancer. It prompts the immune system to recognize tumors as intruders in the body and attack. But not all patients respond well to immunotherapy. Why? Scientists aren't always sure.

23 Jun 2023

$1.9 million grant awarded to explore the effect of antifungal drugs in Crohn's patients

Dr. Iliyan D. Iliev, an associate professor of immunology in medicine in the Division of Gastroenterology and Hepatology, co-director of the Microbiome Core and a member of the Jill Roberts Institute for Research in Inflammatory Bowel Disease (IBD) at Weill Cornell Medicine, is the lead investigator on a grant to Weill Cornell Medicine from The Leona M. and Harry B. Helmsley Charitable Trust to target pathogenic fungi in patients with Crohn's disease.

15 Jun 2023

COVID-19 susceptibility mechanism discovered using a newly created tool

Researchers have discovered a mechanism for COVID-19 susceptibility using a newly created tool. The tool, GASPACHO, captures dynamic changes in gene expression along the innate immune response, allowing researchers to identify genes and molecular pathways associated with disease risk that have previously been too complex to detect or interpret.

15 Jun 2023

IBD patients more likely to have a stroke than people without the disease

People with inflammatory bowel disease (IBD) are more likely to have a stroke than people without the disease, according to a study published in the June 14, 2023, online issue of Neurology, the medical journal of the American Academy of Neurology. The study does not prove that IBD causes stroke; it only shows an association.

14 Jun 2023

New research could one day make common allergies a thing of the past

For years, research and therapies for allergic asthma have been focused largely on targeting the inflammatory cytokines in the body that react to allergens and cause overproduction of mucus, wheezing and difficulty breathing.

14 Jun 2023

So-called “orphan” drugs earn pharmaceutical companies as much money as mainstream medicines

Drugs used to treat rare conditions are earning pharmaceutical companies almost as much as those marketed to the general public, according to a researcher at West Virginia University. Sean Tu, a College of Law professor found lucrative so-called "orphan" drugs earn manufacturing tax credits, have longer patent exclusivities and face easier Food and Drug Administration review.

12 Jun 2023

Crohn's Disease News and Research

Latest Crohn's Disease News and Research

Scientists elucidate mechanism behind early loss of vaccination protection in people with autoimmune disease

Statins may protect IBD patients from colorectal cancer, study finds

Artificial intelligence may influence whether you can get pain medication

Age-related changes in the blood system can exacerbate colon cancer

Doctors and patients try to shame insurers online to reverse prior authorization denials

Beneficial gut bacteria use mucus lining to stay in place, study finds

Experimental drug can reduce symptoms of inflammatory bowel disease in pre-clinical models

Is there an association between migraines and the onset of inflammatory bowel disease?

Maintaining the health of the gut microbiome by a new peptide

Stem cells offer new hope for Crohn's disease treatment

Are antidrug antibodies reducing the effectiveness of rheumatoid arthritis treatment?

Candidate genes for inflammatory bowel disease identified

New drug effective as a treatment against ulcerative colitis, clinical trial shows

Measurable upticks in gut bacteria blooms tied to lupus flare-ups

Research sheds light on how steroids affect cancer Immunotherapy

$1.9 million grant awarded to explore the effect of antifungal drugs in Crohn's patients

COVID-19 susceptibility mechanism discovered using a newly created tool

IBD patients more likely to have a stroke than people without the disease

New research could one day make common allergies a thing of the past

So-called “orphan” drugs earn pharmaceutical companies as much money as mainstream medicines

Innovation in neuroscience drug discovery - eBook eBook

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Crohn's Disease News and Research

Latest Crohn's Disease News and Research

Innovation in neuroscience drug discovery - eBook eBook

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Newsletters you may be interested in